Bristol-Myers Squibb Company (BMY) vs State Street SPDR S&P 500 ETF Trust (SPY)
Over the past 10 years, BMY lagged SPY — 1.08% vs 15.31% annualized total return (price plus dividends).
A side-by-side comparison of Bristol-Myers Squibb Company and State Street SPDR S&P 500 ETF Trust across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — BMY vs SPY
growth of $100 · last 30yDid BMY beat SPY?
Over the past 10 years, BMY lagged SPY — 1.08% vs 15.31% annualized total return (price plus dividends).
Total return (annualized)
| Metric | BMY | SPY |
|---|---|---|
| Total return (1Y) | 18.37% | 24.28%● |
| Total return CAGR (3Y) | 0.46% | 21.12%● |
| Total return CAGR (5Y) | 0.74% | 13.36%● |
| Total return CAGR (10Y) | 1.08% | 15.31%● |
SPY is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Frequently asked
- Has BMY beaten SPY?
- Over the past 10 years, BMY lagged SPY — 1.08% vs 15.31% annualized total return (price plus dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.